The histological subtypes were not significantly different between groups (p = 0.495), with most of the patients having a ductal carcinoma (59.3%—BRCA-negative group; 50%—BRCA1 group; 63.6%—BRCA2 group). This evidence concerns the gene BRCA2 and breast ductal adenocarcinoma.